Menopause is accompanied by a natural decline in oestrogen levels, leading to accelerated bone resorption and shifts in energy regulation. Bisphosphonates, a class of antiresorptive agents commonly ...

Adjunct Faculty, Fay W. Whitney School of Nursing, University of Wyoming, Laramie, Wyoming; Adult and Family Nurse Practitioner and Co-owner, Wright & Associates Family Healthcare, Amherst, New ...

The most common class of medications used to treat osteoporosis is antiresorptive drugs. Common side effects include heartburn, nausea, and trouble swallowing. Osteoporosis is a disease characterized ...

DEAR PEOPLE’S PHARMACY: I have been taking prednisone since 2008 for an autoimmune disease, and I may spend the rest of my life coping with the adverse effects. The major problem now appears to be ...

Data suggest a protective association of bisphosphonates against having a kidney stone diagnosis or procedure. Patients receiving bisphosphonates for osteoporosis treatment are less likely to have ...

The use of bisphosphonates, particularly risedronate, in patients with osteoporosis is linked to a higher risk for acute angle closure but not open-angle glaucoma. Researchers conducted a ...

SEATTLE -- Risk of death was lower in the years after a bisphosphonate was started following a fracture rather than denosumab (Prolia), a target trial emulation found. In adults ages 50 and older who ...

A systematic review and meta-analysis has found that bisphosphonates—medicines commonly used to treat osteoporosis—may offer short-term pain relief for people with complex regional pain syndrome (CRPS ...

Clinical outcomes and epidemiology of acute ischemic stroke in breast cancer patients admitted to U.S. hospital. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...